LENZ Therapeutics, Inc. (LENZ)
LENZ Therapeutics, Inc. operates as a clinical stage company, which develops ophthalmic pharmaceutical products. It offers eye drop product treatment for presbyopia. The company was founded by James McCollum in July 2013 and is headquartered in Del Mar, CA.
Address
201 LOMAS SANTA FE DRIVE, SUITE 300
SOLANA BEACH, CA 92075
Founded
2013
Number of Employees
6
Website
http://www.lenz-tx.com
Buyback
| Buyback Data | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $ Amount Purchased ($ in 000s ) |
- | - | - | - | - | - | - | $42 | $55 | $66 | - | $54 |
| Average Price | - | - | - | - | - | - | - | $2.10 | $2.04 | $1.21 | - | $1.61 |
| # Shares Purchased | - | - | - | - | - | - | - | 19,799 | 27,059 | 54,355 | - | 33,738 |
| Buyback Performance | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Return to Date | - | - | - | - | - | - | - | 900.0% | 927.1% | 1,636.6% | - | 1,206.9% |
| S&P 500 Return to Date | - | - | - | - | - | - | - | 31.7% | 37.3% | 31.3% | - | 33.4% |
| Excess Total Return | - | - | - | - | - | - | - | 868.3% | 889.8% | 1,605.2% | - | 1,173.5% |
| Quartile Rank |
|
|
|
|
|
|
|
|
|
|
|
|
| Percentile Rank | - | - | - | - | - | - | - | 100% | 100% | 100% | - | 100% |
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
Never miss an email alert when insiders at LENZ make a trade.
Creating a free account takes less than one minute